![Continued ) F, schematic illustration of proposed mechanism underlying... | Download Scientific Diagram Continued ) F, schematic illustration of proposed mechanism underlying... | Download Scientific Diagram](https://www.researchgate.net/publication/236600082/figure/fig5/AS:486451839279115@1492990564346/Continued-F-schematic-illustration-of-proposed-mechanism-underlying-the-synergy.png)
Continued ) F, schematic illustration of proposed mechanism underlying... | Download Scientific Diagram
![The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis | Cell Death Discovery The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis | Cell Death Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddiscovery.2015.34/MediaObjects/41420_2015_Article_BFcddiscovery201534_Fig1_HTML.jpg)
The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis | Cell Death Discovery
![Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep24218/MediaObjects/41598_2016_Article_BFsrep24218_Fig6_HTML.jpg)
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports
![Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication | Bentham Science Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/acamc/15/9/004.jpg)
Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication | Bentham Science
![Cancers | Free Full-Text | Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers Cancers | Free Full-Text | Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers](https://www.mdpi.com/cancers/cancers-12-00902/article_deploy/html/images/cancers-12-00902-g001.png)
Cancers | Free Full-Text | Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
![Cancers | Free Full-Text | Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer Cancers | Free Full-Text | Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer](https://www.mdpi.com/cancers/cancers-13-03250/article_deploy/html/images/cancers-13-03250-g001.png)
Cancers | Free Full-Text | Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
![Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep24218/MediaObjects/41598_2016_Article_BFsrep24218_Fig4_HTML.jpg)
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells | Scientific Reports
![MLN4924 specifically inhibits neddylation and suppresses the growth of... | Download Scientific Diagram MLN4924 specifically inhibits neddylation and suppresses the growth of... | Download Scientific Diagram](https://www.researchgate.net/publication/275359720/figure/fig2/AS:294630873681923@1447256882437/MLN4924-specifically-inhibits-neddylation-and-suppresses-the-growth-of-GBM-cells-A.png)
MLN4924 specifically inhibits neddylation and suppresses the growth of... | Download Scientific Diagram
![Frontiers | Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs Frontiers | Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs](https://www.frontiersin.org/files/Articles/573743/fonc-10-01517-HTML/image_m/fonc-10-01517-g001.jpg)
Frontiers | Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs
![Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer | Cell Death Discovery Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer | Cell Death Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41420-020-00296-w/MediaObjects/41420_2020_296_Fig1_HTML.png)
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer | Cell Death Discovery
![The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation - ScienceDirect The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213231716300192-fx1.jpg)
The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation - ScienceDirect
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
![Cardioprotective effect of MLN4924 on ameliorating autophagic flux impairment in myocardial ischemia-reperfusion injury by Sirt1 - ScienceDirect Cardioprotective effect of MLN4924 on ameliorating autophagic flux impairment in myocardial ischemia-reperfusion injury by Sirt1 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213231721002731-ga1.jpg)
Cardioprotective effect of MLN4924 on ameliorating autophagic flux impairment in myocardial ischemia-reperfusion injury by Sirt1 - ScienceDirect
![Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy | Antioxidants & Redox Signaling Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy | Antioxidants & Redox Signaling](https://www.liebertpub.com/cms/10.1089/ars.2013.5795/asset/images/medium/figure6.gif)
Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy | Antioxidants & Redox Signaling
![Figure 5 | Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer Figure 5 | Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer](https://static.hindawi.com/articles/bmri/volume-2014/974309/figures/974309.fig.005.jpg)
Figure 5 | Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer
![Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma - Shida Xiong, Wei Huang, Xiaoqiang Liu, Qian Chen, Yi Ding, Haoxuan Huang, Ru Zhang, Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma - Shida Xiong, Wei Huang, Xiaoqiang Liu, Qian Chen, Yi Ding, Haoxuan Huang, Ru Zhang,](https://journals.sagepub.com/cms/10.1177/09636897221077921/asset/images/large/10.1177_09636897221077921-fig6.jpeg)
Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma - Shida Xiong, Wei Huang, Xiaoqiang Liu, Qian Chen, Yi Ding, Haoxuan Huang, Ru Zhang,
![Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib](https://www.spandidos-publications.com/article_images/or/41/6/OR-41-06-3257-g02.jpg)
Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib
![SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma | Journal of Experimental & Clinical Cancer Research | Full Text SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02284-7/MediaObjects/13046_2022_2284_Fig7_HTML.png)